Successful Treatment of an Immune-Mediated Colitis Induced by Checkpoint Inhibitor Therapy in a Patient with Advanced Melanoma

Immune checkpoint inhibitors (ICIs) have been used as immunotherapeutic agents in several malignancies because of their ability to modify the T cell-mediated response against tumor cells. Dual checkpoint inhibition improves remission rates in patients with metastatic melanoma compared to monotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Paparoupa, Maria, Stupperich, Sophie, Goerg-Reifenberg, Lisa, Wittig, Andreas, Schuppert, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670360/
https://www.ncbi.nlm.nih.gov/pubmed/33250697
http://dx.doi.org/10.1159/000511252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670360/
https://www.ncbi.nlm.nih.gov/pubmed/33250697
http://dx.doi.org/10.1159/000511252

Ejemplares similares